EGFR and cancer: Multiple factors are associated with the ability of cancer cells to develop acquired radioresistance, including signaling pathway dysregulation (e.g., EGFR/PI3K/AKT/mTOR), activation of DNA damage repair mechanisms, the existence of cancer stem cells, alterations in cancer metabolism and epithelial-to-mesenchymal transition (EMT).